|
|
||||||||
From the Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
PURPOSE. 5' nucleotidase (5'N) is a major source of the vasogenic substance adenosine in most tissues. The distribution and relative levels of 5'N and adenosine were examined in neonatal dog inner retina during normal vasculogenesis and oxygen-induced retinopathy (OIR).
METHODS. Animals ranging in age from 1 to 22 days of age were used in this study. Adenosine immunolocalization was performed on frozen sections with an antibody against adenosine conjugated to laevulinic acid using a streptavidin peroxidase technique. Triplicate room air control animals at different postnatal ages and triplicate oxygen-treated animals at different time points during or after hyperoxic insult were analyzed. Adenosine immunoreactivity (AI) and 5'N enzyme histochemical reaction product were quantified using microdensitometry. Adjacent sections were incubated for von Willebrand factor to label blood vessels.
RESULTS. During normal vasculogenesis, AI was most prominent within the inner retina. The peak of immunoreactivity was located at the border of vascularized retina throughout the period of primary retinal vasculogenesis (115 days of age). At 22 days when vasculogenesis was complete, AI decreased within the inner retina. The highest 5'N activity was localized to inner Muller cell processes in inner retina and decreased after vasculogenesis was complete. In animals killed after 4 days of oxygen breathing, the vaso-obliterative stage of OIR, AI and 5'N activity were reduced throughout the retina. During the vasoproliferative stage, AI was markedly elevated at the edge of reforming vasculature as well as throughout the more posterior inner retina where 5'N activity also was elevated. AI was also in intravitreal neovascularization.
CONCLUSIONS. Peak adenosine levels in the inner retina correlated temporally with active vasculogenesis. Adenosine and 5'N levels were reduced in hyperoxia and then returned to above normal levels during the vasoproliferative stage of OIR.
This article has been cited by other articles:
![]() |
T. H. Adair Growth regulation of the vascular system: an emerging role for adenosine Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R283 - R296. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Wijngaarden, D. J. Coster, H. M. Brereton, I. L. Gibbins, and K. A. Williams Strain-Dependent Differences in Oxygen-Induced Retinopathy in the Inbred Rat Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1445 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Bullard, X. Qi, and J. S. Penn Role for Extracellular Signal-Responsive Kinase-1 and -2 in Retinal Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1722 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Montesinos, A. Desai, J.-F. Chen, H. Yee, M. A. Schwarzschild, J. S. Fink, and B. N. Cronstein Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors Am. J. Pathol., June 1, 2002; 160(6): 2009 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M K. Mathews, D S McLeod, C Merges, J Cao, and G A Lutty Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy Br. J. Ophthalmol., June 1, 2002; 86(6): 684 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Mino, P. E. Spoerri, S. Caballero, D. Player, L. Belardinelli, I. Biaggioni, and M. B. Grant Adenosine Receptor Antagonists and Retinal Neovascularization in Vivo Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3320 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Grant, M. I. Davis, S. Caballero, I. Feoktistov, I. Biaggioni, and L. Belardinelli Proliferation, Migration, and ERK Activation in Human Retinal Endothelial Cells through A2B Adenosine Receptor Stimulation Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2068 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wittnich, S. M. Torrance, and C. E. Carlyle Effects of hyperoxia on neonatal myocardial energy status and response to global ischemia Ann. Thorac. Surg., December 1, 2000; 70(6): 2125 - 2131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |